In 2023, US business enterprise R&D expenditure in the manufacture of irradiation, electromedical, and electrotherapeutic equipment stood at approximately USD 2.42 billion. Forecast data from 2024 to 2028 reflect a consistent declining trend, with yearly expenditure decreasing from USD 2.21 billion in 2024 to USD 1.32 billion in 2028. Year-on-year variations indicate a gradual reduction, leading to a negative compound annual growth rate (CAGR) over this period, highlighting reduced investments.
Future trends to watch for include:
- Technological advancements impacting production efficiency.
- Regulatory changes affecting R&D priorities.
- Market dynamics influencing investment in healthcare technology.
- Potential collaborations or acquisitions driving R&D shifts.
